Search | IOVS | ARVO Journals

Showing 1 – 20 of 164

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Fixed-Luminance and Multi-Luminance Flicker Electroretinography Parameters in Patients with Active Birdshot Chorioretinopathy

Arash Maleki; Jordan A Uberroth; Stephen D Anesi; Peter Y Chang; C Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5044. doi:

ARVO Annual Meeting Abstract June 2020

Efficacy of tocilizumab for the treatment of refractory noninfectious retinal vasculitis: a report of preliminary, 3-month outcomes

Jordan Ueberroth; Arash Maleki; Peter Y Chang; Stephen D Anesi; C Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5353. doi:

ARVO Annual Meeting Abstract June 2020

Incidence of Cataract in Eyes with Anterior Uveitis

John H Kempen; George N. Papaliodis; Bernard Rosner; Kurt Dreger; Gui-Shuang Ying; C Stephen Foster; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2069. doi:

ARVO Annual Meeting Abstract June 2020

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Caroline Minkus; Maxwell Pistilli; Kurt Dreger; Tonetta Fitzgerald; Abhishek Payal; Hosne Begum; R Oktay Kacmaz; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt; C Stephen Foster; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2070. doi:

ARVO Annual Meeting Abstract June 2020

Predictors of improvement of magnitude/magnitude D ratio on pattern electroretinogram (pERG) after glaucoma suspect treatment

Marina Peskina; Ayutyanont Napatkamon; Upinder Singh; C Stephen Foster; Stephen D Anesi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3936. doi:

ARVO Annual Meeting Abstract June 2020

Treatment of non-infectious retinal vasculitis using subcutaneous repository corticotropin injection

Stephen D Anesi; Andrew P Stephenson; Peter Y Chang; Alyssa Montieth; Artur Filipowicz; Sarah Syeda; Marisa Walsh; Jamie Lynne Metzinger; C Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5355. doi:

ARVO Annual Meeting Abstract July 2019

Influence of presenting features of atopic keratoconjunctivitis on course of the disease

Marina Peskina; Charles S Foster

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6709. doi:

ARVO Annual Meeting Abstract July 2019

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

John H Kempen; Craig W Newcomb; Charles S Foster; Douglas A Jabs; Grace Levy-Clarke; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; Jeanine M Buchanich

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3854. doi:

ARVO Annual Meeting Abstract July 2019

Retinal Vasculitis in HLA-B27 Associated Anterior Uveitis on Wide-Field Anigiography

Jie Gao; Marina Peskina; Marisa Walsh; Peter Chang; Stephen D Anesi; Charles S Foster

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4079. doi:

ARVO Annual Meeting Abstract July 2019

Factors Predictive of Remission of Chronic Anterior Uveitis

Lucia Sobrin; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; Pichaporn Artornsombudh; Siddharth Pujari; Charles Stephen Foster; Douglas A Jabs; James T Rosenbaum; Grace Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6683. doi:

ARVO Annual Meeting Abstract July 2018

Long-term Maintenance Therapy of Rituximab in Treatment of Noninfectious Scleritis

Swetha Dhanireddy; Robert Swan; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):426. doi:

ARVO Annual Meeting Abstract July 2018

Long-Term Efficacy and Safety of Adalimumab by Immunosuppressant Use in Patients with Non-Infectious Uveitis in the VISUAL III Trial

Yan J Guex-Crosier; C. Stephen Foster; Kei Nakai; Hiroshi Goto; Kevin Douglas; Sophia Pathai; Martina Kron; Alexandra P Song; Joachim Van Calster; Alfredo Adan Civera

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5951. doi:

Biochemistry and Molecular Biology January 2018

Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration

PDF

Nathaniel F. Henneman; Stephanie L. Foster; Micah A. Chrenek; Jana T. Sellers; Charles B. Wright; Robin H. Schmidt; John M. Nickerson; Jeffrey H. Boatright
TAGS: language morphology, mice, morphology, retina, retinal degeneration, light exposure, oxidation-reduction, electroretinography
Invest. Ophthalmol. Vis. Sci.. 2018; 59(1):45-53. doi: https://doi.org/10.1167/iovs.17-22132

ARVO Annual Meeting Abstract June 2017

Corneal infections: targeted eradication through antibiotic functionalized polymers.

Natalya Doroshenko; Stephen Rimmer; Simon Foster; Sheila MacNeil; Ian Douglas

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4293. doi:

ARVO Annual Meeting Abstract June 2017

Systemic treatment with xanthohumol protects against light-induced retinal degeneration and maintains retinal redox potential

Nathaniel F Henneman; Stephanie Foster; Preston E Girardot; Jeffrey H Boatright

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5254. doi:

ARVO Annual Meeting Abstract June 2017

Treatment of scleritis and uveitis in granulomatosis with polyangiitis using cyclophosphamide or rituximab

Aseef Ahmed; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):513. doi:

ARVO Annual Meeting Abstract June 2017

Delayed Acceleration of Severity in Recurrent Acute HLA-B27 Associated Anterior Uveitis

Karen Small; Jing Hua; Alexander Cohn; Stephen D Anesi; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):524. doi:

ARVO Annual Meeting Abstract June 2017

Long-term outcomes in Juvenile idiopathic arthritis-associated uveitis

Sarah Syeda; Nakhoul Nakhoul; Buraa Kubaisi; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):525. doi:

ARVO Annual Meeting Abstract June 2017

Characterization of corneal endothelial pseudoguttata in the setting of anterior uveitis

Doran Spencer; Stephen D Anesi; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):557. doi:

ARVO Annual Meeting Abstract June 2017

A Randomized, Comparator-Controlled Phase 2 Clinical Trial of ADX-102 Ophthalmic Solution in Noninfectious Anterior Uveitis

John D Sheppard; Todd Brady; C. Stephen Foster; Kenneth J Mandell; Scott L Young

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1231. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Fixed-Luminance and Multi-Luminance Flicker Electroretinography Parameters in Patients with Active Birdshot Chorioretinopathy

Efficacy of tocilizumab for the treatment of refractory noninfectious retinal vasculitis: a report of preliminary, 3-month outcomes

Incidence of Cataract in Eyes with Anterior Uveitis

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Predictors of improvement of magnitude/magnitude D ratio on pattern electroretinogram (pERG) after glaucoma suspect treatment

Treatment of non-infectious retinal vasculitis using subcutaneous repository corticotropin injection

Influence of presenting features of atopic keratoconjunctivitis on course of the disease

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

Retinal Vasculitis in HLA-B27 Associated Anterior Uveitis on Wide-Field Anigiography

Factors Predictive of Remission of Chronic Anterior Uveitis

Long-term Maintenance Therapy of Rituximab in Treatment of Noninfectious Scleritis

Long-Term Efficacy and Safety of Adalimumab by Immunosuppressant Use in Patients with Non-Infectious Uveitis in the VISUAL III Trial

Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration

Corneal infections: targeted eradication through antibiotic functionalized polymers.

Systemic treatment with xanthohumol protects against light-induced retinal degeneration and maintains retinal redox potential

Treatment of scleritis and uveitis in granulomatosis with polyangiitis using cyclophosphamide or rituximab

Delayed Acceleration of Severity in Recurrent Acute HLA-B27 Associated Anterior Uveitis

Long-term outcomes in Juvenile idiopathic arthritis-associated uveitis

Characterization of corneal endothelial pseudoguttata in the setting of anterior uveitis

A Randomized, Comparator-Controlled Phase 2 Clinical Trial of ADX-102 Ophthalmic Solution in Noninfectious Anterior Uveitis

To View More...

You must be signed into an individual account to use this feature.